CD4 and melanoma: However, there is an expansion of a population of BDCA1+CD14+ cells (possibly corresponding to DC3s) expressing PD-L1 in melanoma patients, which can be found in DC vaccines, and responsible for suppressing CD4 T-cell responses [92].